Volgen
Francesco Tabaro
Francesco Tabaro
EMBL
Geverifieerd e-mailadres voor embl.it
Titel
Geciteerd door
Geciteerd door
Jaar
DisProt 7.0: a major update of the database of disordered proteins
D Piovesan, F Tabaro, I Mičetić, M Necci, F Quaglia, CJ Oldfield, ...
Nucleic acids research 45 (D1), D219-D227, 2017
3252017
MobiDB 3.0: more annotations for intrinsic disorder, conformational diversity and interactions in proteins
D Piovesan, F Tabaro, L Paladin, M Necci, I Mičetić, C Camilloni, N Davey, ...
Nucleic acids research 46 (D1), D471-D476, 2018
2162018
Computational identification of prion-like RNA-binding proteins that form liquid phase-separated condensates
G Orlando, D Raimondi, F Tabaro, F Codice, Y Moreau, WF Vranken
Bioinformatics 35 (22), 4617-4623, 2019
462019
VHLdb: A database of von Hippel-Lindau protein interactors and mutations
F Tabaro, G Minervini, F Sundus, F Quaglia, E Leonardi, D Piovesan, ...
Scientific Reports 6 (1), 31128, 2016
402016
Prediction of disordered regions in proteins with recurrent neural networks and protein dynamics
G Orlando, D Raimondi, F Codice, F Tabaro, W Vranken
Journal of Molecular Biology 434 (12), 167579, 2022
302022
iCn3D: from web-based 3D viewer to structural analysis tool in batch mode
J Wang, P Youkharibache, A Marchler-Bauer, C Lanczycki, D Zhang, S Lu, ...
Frontiers in molecular biosciences 9, 831740, 2022
302022
Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors
G Minervini, F Quaglia, F Tabaro, SCE Tosatto
PLoS Computational Biology 15 (4), e1006478, 2019
242019
Large-scale in-silico statistical mutagenesis analysis sheds light on the deleteriousness landscape of the human proteome
D Raimondi, G Orlando, F Tabaro, T Lenaerts, M Rooman, Y Moreau, ...
Scientific reports 8 (1), 16980, 2018
112018
Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression
J Uusi-Mäkelä, E Afyounian, F Tabaro, T Häkkinen, A Lussana, ...
bioRxiv, 2020.09. 08.287268, 2020
72020
RAS and PP2A activities converge on epigenetic gene regulation
A Aakula, M Sharma, F Tabaro, R Nätkin, J Kamila, H Honkanen, ...
Life science alliance 6 (5), 2023
52023
CNTNAP2 mutations and autosomal dominant epilepsy with auditory features
E Leonardi, E Dazzo, MC Aspromonte, F Tabaro, S Pascarelli, ...
Epilepsy Research 139, 51-53, 2018
52018
Insights into the molecular features of the von Hippel–Lindau-like protein
G Minervini, F Quaglia, F Tabaro, SCE Tosatto
Amino acids 51, 1461-1474, 2019
42019
Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk‐reducing salpingo‐oophorectomies
K Veskimäe, S Staff, F Tabaro, M Nykter, J Isola, J Mäenpää
Genes, Chromosomes and Cancer 54 (5), 276-287, 2015
42015
Insights into the molecular features of the von Hippel-Lindau like protein
F Quaglia, G Minervini, F Tabaro, SCE Tosatto
BioRxiv, 407353, 2018
22018
Trim66 paternal deficiency causes intrauterine overgrowth
M Mielnicka, F Tabaro, R Sureka, B Acurzio, R Paoletti, F Scavizzi, ...
bioRxiv, 2024.02. 12.579976, 2024
2024
RAS and PP2A activities converge on phosphoregulation of epigenetic complexes in cancer
M Sharma, A Aakula, F Tabaro, H Honkanen, J Kamila, M Schapira, ...
Cancer Research 83 (7_Supplement), 4727-4727, 2023
2023
Chromatin repressor complex as a converge point of RAS and PP2A activities in lung cancer
M Sharma, A Aakula, F Tabaro, K Pavic, R Huhtaniemi, M Nykter, ...
Cancer Research 82 (12_Supplement), 2958-2958, 2022
2022
Analysis of Chromatin and Proteins in Cancer
F Tabaro
Tampere University, 2020
2020
Abstract LB-096: Chromatin alterations in human prostate cancer
JI Tuominen, E Afyounian, F Tabaro, T Häkkinen, A Shcherban, M Annala, ...
Cancer Research 79 (13_Supplement), LB-096-LB-096, 2019
2019
VHL-DB: A DATABASE OF VON HIPPEL-LINDAU
F TABARO, G MINERVINI, F SUNDUS, E LEONARDI, D PIOVESAN, ...
PROGRAMME “PROTEINE2016”, 43, 2016
2016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20